Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture. - Wikidata - awgldk - TriplyDB

Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.

Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.

http://www.wikidata.org/entity/Q33989307

about

Clinical risk factors for recurrent fracture after hip fracture: a prospective study.

P2860

Q48908802-DCF2F0E8-AC7B-4317-BD54-19BB76558277

P2860

Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.

http://www.wikidata.org/entity/Q33989307

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Differences in exposure to sti ...... versus trochanteric fracture.

@ast

Differences in exposure to sti ...... versus trochanteric fracture.

@en

type

label

Differences in exposure to sti ...... versus trochanteric fracture.

@ast

Differences in exposure to sti ...... versus trochanteric fracture.

@en

prefLabel

Differences in exposure to sti ...... versus trochanteric fracture.

@ast

Differences in exposure to sti ...... versus trochanteric fracture.

@en

P1433

Q33989307-2C01F732-037E-4123-8B1F-78B71C817B67

P1476

Q33989307-41C31C97-9140-4CD5-AEEC-D0429756BA24

P2093

Q33989307-120DDD86-5EE9-444D-9567-5A9CB6A49824

Q33989307-3E1A1D07-BC9F-4D27-B007-F31B3147DC89

Q33989307-821A760D-5585-4199-8CBB-8BD1B35B4A56

Q33989307-99F6DB5A-7E52-4A39-B79E-2576A6AC4245

Q33989307-AD0581C6-4999-40BF-8957-58B3FB6D97EB

Q33989307-AEDE1CB0-03C1-4886-9E14-E2854954AAA7

Q33989307-B769DEE7-CE84-4DCE-978A-4D751D821684

Q33989307-C2B80420-B852-4EF6-AB0A-37E3CAA4CD50

P2860

Q33989307-04F9D209-FBE8-4710-92ED-4B38C719CA56

Q33989307-0A58B469-702A-4AE3-891F-AA501370A646

Q33989307-0C4C92AC-0958-4F85-8BE3-886E85701120

Q33989307-152CB898-D714-42AE-BA76-B3D93C077CAB

Q33989307-15661239-83D3-4E0F-A9E9-FA0CDDD34FC8

Q33989307-1B37ADDA-3E83-4AB3-B81A-CDD727061CD2

Q33989307-22356451-0193-4976-B531-987EA486F6C4

Q33989307-4FF0C68A-E4F3-43EB-AD65-C8447F40CDE0

Q33989307-6239CF70-25E4-468D-A49A-2DC6B46D13E9

Q33989307-6EB71470-BD5B-4ADD-AA64-6DC65BAAFADE

P304

Q33989307-2E8360D7-6A32-4238-B536-F5F2E30904A7

P31

Q33989307-E38C81B5-BDBF-455E-86CA-6CE5D2450CC1

P356

Q33989307-9BE8FEC4-DBED-408B-995E-7661917E2876

P433

Q33989307-FD141E5A-40F5-4191-BF3C-545ACA75343C

P478

Q33989307-510AF0B1-91C2-43AD-8C8B-311B670DC1C3

P577

Q33989307-9D5FB753-F2D1-4917-959F-22F8DD238F4A

P5875

Q33989307-AE49984A-C2F1-49AC-B36C-B364859FB778

P698

Q33989307-DF159D29-BE64-4EBC-882A-040ECFB98676

P932

Q33989307-0D449678-16AA-47B0-8A29-A361EFCB60F3

P356

P1433

P1476

Differences in exposure to sti ...... versus trochanteric fracture.

@en

P2093

D J Baylink

http://www.w3.org/2001/XMLSchema#string

D Vanderschueren

http://www.w3.org/2001/XMLSchema#string

K Venken

http://www.w3.org/2001/XMLSchema#string

P Geusens

http://www.w3.org/2001/XMLSchema#string

P Haentjens

http://www.w3.org/2001/XMLSchema#string

R Bouillon

http://www.w3.org/2001/XMLSchema#string

S Boonen

http://www.w3.org/2001/XMLSchema#string

S Mohan

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-like growth factors and their binding proteins: biological actions

Growth factors to stimulate bone formation.

Bone mineral density in patients with cervical and trochanteric fractures of the proximal femur.

Mortality associated with hip fractures in a single geriatric hospital and residential health facility: a ten-year review.

Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells.

Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.

Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women.

Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss.

Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study.

Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids.

P304

175-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AGEING/AFI013

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8019058

http://www.w3.org/2001/XMLSchema#string

P698

15713863

http://www.w3.org/2001/XMLSchema#string

P932

2903003

http://www.w3.org/2001/XMLSchema#string